生物医药行业创新物流解决方案提供商Cellbox Solutions完成A轮融资，融资总额达500万欧元-动脉网

Cellbox Solutions Completes Series A Funding Round Totaling 5 Million Euros

D-Pharm 等信源发布 2026-10-21 12:08



可切换为仅中文







Cellbox Solutions, a technology company specializing in warm-chain logistics, has successfully completed its Series A funding round with a total volume of 5 million euros. With the additional capital, the company is driving the further development of its business model and expanding its offerings to include integrated logistics solutions for cells, tissues, organoids, and other sensitive biological materials..

Cellbox Solutions 是一家专注于温链物流的科技公司，已成功完成总额为 500 万欧元的 A 轮融资。凭借新增资本，该公司正推动其商业模式的进一步发展，并将服务范围扩展至为细胞、组织、类器官及其他敏感生物材料提供综合物流解决方案。

The funding lays the foundation for the next phase of commercial growth and builds on the technological, product-related, and regulatory advances Cellbox Solutions has achieved in recent years. The focus is on expanding the existing logistics offering: In the future, controlled transport under physiological conditions will be even more closely integrated with complementary logistics and services..

此次融资为下一阶段的商业增长奠定了基础，并依托 Cellbox Solutions 近年来在技术、产品和监管方面取得的进展。重点在于扩展现有的物流服务组合：未来，生理条件下的可控运输将与互补的物流及服务更加紧密地整合。

After Cellbox Solutions had already secured an initial round of funding totaling approximately 3.5 million euros in March 2026, the company was able to attract additional investors for this financing round. These include members of Baltic Business Angels Invest GmbH, a Canadian family office, and an unnamed investor with extensive experience in pharmaceutical logistics.

在Cellbox Solutions于2026年3月已获得总计约350万欧元的首轮融资后，该公司又为本轮融资吸引了更多投资者。其中包括Baltic Business Angels Invest GmbH的成员、一家加拿大家族办公室，以及一位在医药物流领域拥有丰富经验的匿名投资者。

In addition, existing investors NRW.BANK and Fraunhofer Venture participated in the financing once again. The first closing of the financing round was led by Companisto..

此外，现有投资者NRW.BANK和Fraunhofer Venture再次参与了融资。本轮融资的首次关闭由Companisto领投。

Cellbox™ Go and Cellbox™ Shipper form the technological foundation for the further expansion of the business model. Both incubators enable controlled transport under defined temperature and CO₂ conditions by land and air and are already being used internationally in research and in cell therapy applications..

Cellbox™ Go 和 Cellbox™ Shipper 构成了商业模式进一步扩展的技术基础。这两款培养箱均能实现在规定的温度和二氧化碳条件下通过陆路和航空进行受控运输，并已在国际上的研究和细胞治疗应用中得到使用。

With over 400 Cellbox™ incubators on the market, a growing customer base, and a regulatory framework that includes Drug Master Files for the Cellbox™ product family, the company is well-positioned to expand its commercial offerings. The Cellbox™ systems are combined with rental and transportation services as well as recurring services such as monitoring, fleet management, and shipping coordination.

凭借市场上超过400台Cellbox™培养箱、不断扩大的客户群，以及包含针对Cellbox™产品系列的主药物文件（DMF）的监管框架，该公司已具备有利条件来扩展其商业产品组合。Cellbox™系统与租赁和运输服务相结合，并提供监测、车队管理和运输协调等持续性服务。

This approach is intended to provide customers with even more flexible and comprehensive support for their logistics processes in the future..

该方法旨在未来为客户提供更加灵活和全面的物流流程支持。

“In recent years, we have laid a solid foundation for the controlled transport of live biological materials,” said Prof. Dr. Kathrin Adlkofer, founder and CEO of Cellbox Solutions. “With the completion of our Series A funding round, we are now expanding our established warm-chain technology platform into a broader offering for physiological logistics.

“近年来，我们为活体生物材料的可控运输奠定了坚实基础。”Cellbox Solutions 创始人兼首席执行官 Kathrin Adlkofer 博士表示。“随着 A 轮融资的完成，我们现在正将已成熟的温链技术平台扩展为更广泛的生理物流解决方案。”

This will enable us to support our customers even more comprehensively throughout their logistics processes while simultaneously expanding our presence in key international markets.”.

这将使我们能够在整个物流流程中更全面地支持客户，同时扩大我们在关键国际市场的影响力。

In the long term, Cellbox Solutions aims to establish physiological logistics as a scalable approach for transporting biological materials that require controlled environmental conditions. To this end, the company is further expanding its activities in Europe, Asia, and North America and is increasingly focusing on strategic partnerships with logistics service providers..

从长远来看，Cellbox Solutions 旨在将生理物流确立为一种可扩展的方法，用于运输需要受控环境条件的生物材料。为此，公司正在进一步拓展其在欧洲、亚洲和北美的业务，并日益专注于与物流服务提供商建立战略合作伙伴关系。

“The completion of the Series A funding round provides us with additional capital to further develop the business model centered on our technologies. We are expanding our range of rental and recurring services and integrating them with transportation, monitoring, and complementary logistics services.

“A轮融资的完成为我们提供了额外资金，以进一步发展以我们的技术为核心的商业模式。我们正在扩大租赁和经常性服务的范围，并将其与运输、监控及配套物流服务相整合。”

This enables us to build long-term customer relationships and establish our scalable service model in multiple markets. Our focus is now on translating the strengths of the Cellbox™ platform into sustainable growth,” explained Dr. Bernd Muehlenweg, CBO & CFO at Cellbox Solutions..

“这使我们能够建立长期的客户关系，并在多个市场确立我们可扩展的服务模式。我们目前的重心是将 Cellbox™ 平台的优势转化为可持续增长。”Cellbox Solutions 首席商务官兼首席财务官 Bernd Muehlenweg 博士解释道。

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar.

注意：本文已由计算机系统自动翻译，未经人工干预。LUMITOS 提供这些自动翻译，旨在呈现更广泛的最新新闻。由于本文系自动翻译，可能存在词汇、句法或语法错误。

The original article in German can be found .

德语原文可在此处查阅。

here

这里

。

https://www.bionity.com/en/news/1190124/cellbox-solutions-completes-series-a-funding-round-totaling-5-million-euros.html

Cellbox raises €3.5 million for warm-chain logistics of living cells

Cellbox 为活细胞温链物流筹集 350 万欧元

Technology company strengthens management team with former Evotec manager for international expansion in cell and gene therapy

科技公司聘请前Evotec高管加入管理层，以推动细胞与基因治疗领域的国际扩张

Read news